Patent · US Active

Immunodeficient non-human animal

US10820580B2 · kind B2 · utility

4Cited by

2References

7Claims

0Family size

Assignee

Beijing Biocytogen Co., Ltd · CN

Inventors

Yuelei Shen · Beijing, CN
Yang Bai · Beijing, CN
Meiling Zhang · Beijing, CN
Jiawei Yao · Beijing, CN
Rui Huang · Beijing, CN
Yanan Guo · Beijing, CN

Key dates

Filing date	Jun 7, 2019
Grant date	Nov 3, 2020
Priority date	—
Expiry date	Jun 7, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/20
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure relates to the genetically modified non-human animals that have a disruption at the endogenous CD132 gene (e.g., CD132 knockout), and methods of use thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.